Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
Archer-Daniels-Midland heads into its November 3 earnings with a quietly rebuilding short book, a divided Street, and retail attention running notably hot against its own recent history.
The most interesting tension this week is the divergence between short interest, which has climbed nearly 24% over the past month to just under 3% of free float, and a borrow market that is as loose as it has ever been. Short interest is not large in absolute terms at roughly 14.4 million shares, but the monthly build is the sharpest in the 30-day window shown. That pace of accumulation, from around 11.3 million shares in early September to 14.4 million now, is the kind of steady grind that tends to reflect a conviction trade rather than a technical position. Yet the lending market tells a completely different story. Availability has actually expanded over the week, now registering over 5,260% relative to the outstanding short interest, meaning there are more than 52 shares available to borrow for every one already shorted. Cost to borrow has collapsed to 0.22%, more than half where it was just a week ago. Borrow is plentiful and cheap. The shorts are not squeezed, and there is no sign of anyone scrambling to cover.
Options positioning offers little additional directional signal. The put/call ratio of 0.54 sits fractionally below its 20-day average of 0.55, with a z-score near zero. Nothing in the options market reads as either defensive hedging or unusual call accumulation. The PCR has tracked a narrow range through September and October, suggesting traders are neither leaning hard into downside protection nor reaching for upside. Given that earnings land in 26 days, the absence of any obvious skew is itself notable.
The Street is clearly undecided on ADM's direction. The most consequential move in recent months came in early August when Morgan Stanley upgraded the stock from Underweight to Equal-Weight, lifting its target from $60 to $79. That put the stock within reach of where it trades now at $81.34. Barclays and BMO both raised targets on the same day, though neither changed their neutral-to-cautious ratings. The lone bull with real conviction is UBS, which has maintained a Buy with a $95 target since June. JP Morgan remains Underweight at $74. The consensus price target sits at $80.40, which is marginally below the current price, a rare situation where the average analyst view implies the stock is already fully valued. Analyst data here is around two to three weeks old, so treat the precise targets as directionally useful rather than definitive. Valuation multiples add texture: the PE of 14.4x has compressed about 5% over 30 days, while EV/EBITDA at 9.6x has drifted lower as well. Factor scores give ADM high marks for EPS surprise (85th percentile) and 90-day earnings momentum (86th percentile), but the 12-month forward earnings growth rank is weak at 32, consistent with a stock that has beaten lowered expectations rather than one with an accelerating top line.
One data point stands out from the alt data layer. Wikipedia page views for ADM are running at a z-score of 2.39 against the stock's own 90-day history, a reading as of September 22 that places retail attention well above recent norms. The Wikimedia Foundation data is an attention signal, not a revenue indicator, and none of ADM's five tracked alt-data series has been measured to lead its reported figures. Still, heightened retail attention into an earnings cycle with a divided Street and a building short position is worth noting as context.
Institutional holders are broadly stable. BlackRock added around 1.76 million shares in the most recent reported quarter, and Charles Schwab Investment Management added over 1.3 million. Wellington Management, which trimmed its stake from 5.2% to 3.6% per its May 13G/A filing, remains the more notable flow on the other side, though those figures are as last disclosed and positions can shift without a further filing. No activist holder is registered on the 13D/G roll, and insider activity in the past 90 days nets to zero, with recent Form 4 filings covering only compensation-related transactions and a small tax-withholding sale.
Close peers BG and DAR both fell on the week, off 1.3% and 1.1% respectively, while ADM gained 2.5%, the outperformance appearing somewhat idiosyncratic rather than a sector move. The next clear test is the November 3 earnings print, where the question for the positioning is less about whether the short book is large enough to matter and more about whether the monthly accumulation continues into the release or begins to unwind as the event approaches.
See the live data behind this article on ORTEX.
Open ADM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.
